TRMT61B and central nervous system cancer: Surprisingly, m1A also has such potential, as regulators of m1A modification markedly affected glioma prognosis, with NML, TRMT6, TRMT10C, TRMT61B, ALKBH1, ALKBH3, YTHDF1, YTHDF2, and YTHDF3 as risk factors but YTHDC1 as a protective factor (Figure 2).